Global Alcoholic Hepatitis Treatment Market Report 2023: Forecast Market Size, Growth Rate And Key Drivers

1 Nov, 2023

The global alcoholic hepatitis treatment market is expected to grow from $2.70 billion in 2022 to $2.95 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The alcoholic hepatitis treatment market is expected to reach $3.95 billion in 2027 at a CAGR of 7.6%.

Global Alcoholic Hepatitis Treatment Market Key Driver

The growing prevalence of liver diseases attributed to alcohol consumption is expected to drive the expansion of the alcoholic hepatitis treatment market moving forward. Alcoholic liver disease arises from impairment of the liver's functioning. The liver plays a crucial role in various bodily processes, such as blood purification and bile production for aiding digestion. Treatment for alcoholic hepatitis is employed to address liver inflammation in some patients. Severe cases of alcoholic hepatitis may necessitate hospital-based therapy.

Get a sample of the global alcoholic hepatitis treatment market report

Global Alcoholic Hepatitis Treatment Market Segments

The global alcoholic hepatitis treatment market is segmented -
1) By Treatment: Drug Treatment, Stem Cell Therapy
2) By Drug Class: Corticosteroids, Hemorheologic Agents, Monoclonal Antibodies, Anabolic Steroids, Other Drug Classes
3) By Route of Administration: Oral, Injectable
4) By Application: Hospital, Clinic, Private Treatment Center
5) By Geography: The regions covered in the alcoholic hepatitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global alcoholic hepatitis treatment market.

Major Alcoholic Hepatitis Treatment Industry Players

  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • F. Hoffmann-La Roche Ltd.
  • AbbVie Inc.
  • Novartis AG
  • Sanofi PLC
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Torrent Pharmaceuticals Ltd.
  • Takeda Pharmaceutical Company Limited
  • Get the full global alcoholic hepatitis treatment market report

    Alcoholic Hepatitis Treatment Market Overview

    Alcoholic hepatitis treatment refers to treatments provided for giving up alcohol and receiving treatments to lessen the symptoms of liver damage. Alcoholic hepatitis is treated in part by abstaining from alcohol and receiving therapy to minimize the warning signs and symptoms of liver damage.

    Alcoholic Hepatitis Treatment Global Market Report 2023 provides data on the global alcoholic hepatitis treatment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The alcoholic hepatitis treatment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.